 NEW YORK, March 07, 2022 GLOBE NEWSWIRE -- Indaptus Therapeutics, Inc. Nasdaq: INDP Indaptus or the Company, today announced that Jeffrey Meckler, Chief Executive Officer, will participate in an on demand pre-recorded presentation at the 34th Annual ROTH Conference which is taking place March 14 15, 2022. 